Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression

INTRODUCTION: COMP360 is a synthetic, proprietary, purified form of psilocybin in development for treatment-resistant depression (TRD) with FDA Breakthrough Therapy designation. In a recent phase IIb study, COMP360 psilocybin 25mg was superior to 1mg on change from baseline (CFB) to Week 3 on the Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodwin, G. M., Marwood, L., Mistry, S., Nowakowska, A., Simmons, H., Tsai, J., Williams, S., Young, M. B., Malievskaia, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595939/
http://dx.doi.org/10.1192/j.eurpsy.2023.273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595939/
http://dx.doi.org/10.1192/j.eurpsy.2023.273

Ejemplares similares